D Castelnau

1.5k total citations
31 papers, 1.2k citations indexed

About

D Castelnau is a scholar working on Clinical Psychology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, D Castelnau has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Clinical Psychology, 11 papers in Psychiatry and Mental health and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in D Castelnau's work include Suicide and Self-Harm Studies (11 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). D Castelnau is often cited by papers focused on Suicide and Self-Harm Studies (11 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Nicotinic Acetylcholine Receptors Study (5 papers). D Castelnau collaborates with scholars based in France, Switzerland and Canada. D Castelnau's co-authors include Alain Malafosse, Fabrice Jollant, Philippe Courtet, Frank Bellivier, Marion Leboyer, Catherine Burési, Bernard Astruc, Régis Verdier, Sébastien Guillaume and Isabelle Jaussent and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Molecular Psychiatry.

In The Last Decade

D Castelnau

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Castelnau France 13 648 403 339 211 192 31 1.2k
Nadia Chawky Canada 18 1.0k 1.6× 372 0.9× 326 1.0× 286 1.4× 94 0.5× 25 1.7k
A. Roy United States 24 1.1k 1.6× 579 1.4× 301 0.9× 135 0.6× 118 0.6× 33 1.8k
Dominique Mouthon Switzerland 12 445 0.7× 355 0.9× 304 0.9× 327 1.5× 67 0.3× 15 1.1k
Catherine Cahill Australia 16 578 0.9× 514 1.3× 117 0.3× 94 0.4× 136 0.7× 29 1.2k
Angela M. Murray United States 12 1.6k 2.4× 563 1.4× 340 1.0× 193 0.9× 162 0.8× 13 2.2k
Gunnar Rylander Sweden 17 282 0.4× 218 0.5× 299 0.9× 197 0.9× 70 0.4× 23 950
Tuula Ilonen Finland 19 398 0.6× 636 1.6× 207 0.6× 89 0.4× 178 0.9× 59 1.2k
G. Moi Italy 17 276 0.4× 162 0.4× 342 1.0× 129 0.6× 112 0.6× 19 864
Steven O. Moldin United States 21 396 0.6× 479 1.2× 97 0.3× 151 0.7× 162 0.8× 34 1.2k
Kristi A. Sacco United States 19 213 0.3× 353 0.9× 290 0.9× 620 2.9× 197 1.0× 20 1.4k

Countries citing papers authored by D Castelnau

Since Specialization
Citations

This map shows the geographic impact of D Castelnau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Castelnau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Castelnau more than expected).

Fields of papers citing papers by D Castelnau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Castelnau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Castelnau. The network helps show where D Castelnau may publish in the future.

Co-authorship network of co-authors of D Castelnau

This figure shows the co-authorship network connecting the top 25 collaborators of D Castelnau. A scholar is included among the top collaborators of D Castelnau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Castelnau. D Castelnau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jollant, Fabrice, Catherine Burési, Sébastien Guillaume, et al.. (2007). The influence of four serotonin‐related genes on decision‐making in suicide attempters. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 144B(5). 615–624. 70 indexed citations
2.
Jollant, Fabrice, Sébastien Guillaume, Isabelle Jaussent, et al.. (2007). Psychiatric diagnoses and personality traits associated with disadvantageous decision-making. European Psychiatry. 22(7). 455–461. 66 indexed citations
3.
Jollant, Fabrice, Sébastien Guillaume, Isabelle Jaussent, et al.. (2006). Impaired decision-making in suicide attempters may increase the risk of problems in affective relationships. Journal of Affective Disorders. 99(1-3). 59–62. 76 indexed citations
4.
Courtet, Philippe, Fabrice Jollant, D Castelnau, Catherine Burési, & Alain Malafosse. (2005). Suicidal behavior: Relationship between phenotype and serotonergic genotype. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 133C(1). 25–33. 69 indexed citations
5.
Jollant, Fabrice, Frank Bellivier, Marion Leboyer, et al.. (2005). Impaired Decision Making in Suicide Attempters. American Journal of Psychiatry. 162(2). 304–310. 402 indexed citations
6.
Astruc, Bernard, et al.. (2004). A History of Major Depressive Disorder Influences Intent to Die in Violent Suicide Attempters. The Journal of Clinical Psychiatry. 65(5). 690–695. 23 indexed citations
7.
Courtet, Philippe, Fabrice Jollant, D Castelnau, et al.. (2004). [Implication of genes of the serotonergic system on vulnerability to suicidal behavior].. PubMed. 29(5). 350–9. 9 indexed citations
8.
Courtet, Philippe, Marie‐Christine Picot, Frank Bellivier, et al.. (2003). Serotonin transporter gene may be involved in short-term risk of subsequent suicide attempts. Biological Psychiatry. 55(1). 46–51. 72 indexed citations
9.
Courtet, Philippe, Catherine Burési, Mocrane Abbar, et al.. (2002). No association between non‐violent suicidal behavior and the serotonin transporter promoter polymorphism. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 116B(1). 72–76. 28 indexed citations
10.
Courtet, P., et al.. (2002). The serotonin transporter gene may be involved in the short-term risk of subsequent suicide attempt. European Neuropsychopharmacology. 12. 423–424. 1 indexed citations
11.
Courtet, P., Patrick Baud, Mocrane Abbar, et al.. (2001). Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene. Molecular Psychiatry. 6(3). 338–341. 142 indexed citations
12.
Malafosse, Alain, Marion Leboyer, Thierry d’Amato, et al.. (1997). Manic Depressive Illness and Tyrosine Hydroxylase Gene: Linkage Heterogeneity and Association. Neurobiology of Disease. 4(5). 337–349. 14 indexed citations
13.
Abbar, M., Philippe Courtet, Alain Malafosse, & D Castelnau. (1996). Génétique épidémiologique et moléculaire des conduites suicidaires.. 22. 19–24. 2 indexed citations
14.
Abbar, M., Bertrand Carlander, & D Castelnau. (1996). Tricyclics and malignant syndrome. European Psychiatry. 11(4). 212–213. 2 indexed citations
15.
Abbar, Mocrane, Philippe Courtet, Alain Malafosse, & D Castelnau. (1996). [Epidemiologic and molecular genetic of suicidal behavior].. PubMed. 22 Spec No 4. 19–24. 3 indexed citations
16.
Waksman, Gilles, et al.. (1993). D2 dopamine receptor gene and alcoholism. Journal of Psychiatric Research. 27(2). 173–179. 73 indexed citations
17.
Abbar, Mocrane, et al.. (1992). [Clinical study of 5 families with bipolar disorder].. PubMed. 18 Spec No 1. 78–82. 1 indexed citations
18.
Abbar, Mocrane, et al.. (1992). AN ASSOCIATION STUDY BETWEEN SUICIDAL BEHAVIOR AND TRYPTOPHAN HYDROXYLASE DNA MARKERS.. Clinical Neuropharmacology. 15. 299B–299B.
19.
Patris, Michel, S Brion, Grzegorz Burnat, et al.. (1990). A double‐blind multicentre comparison of remoxipride, at two dose levels, and haloperidol. Acta Psychiatrica Scandinavica. 82(S358). 78–82. 24 indexed citations
20.
Boyer, Richard, et al.. (1977). [Psychotropic agents and stomatology].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 2(4). 733–42. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026